newsThe US Food & Drug Administration (FDA) has approved the…
21 November 2022 | By Catherine Eckford (European Pharmaceutical Review)
The US Food & Drug Administration (FDA) has approved the first-in-human gene therapy trial for heart failure patients with preserved ejection fraction.